TITLE:
Comparing 3 Schedules of Alimta Plus Gemzar

CONDITION:
Carcinoma, Non-Small-Cell Lung

INTERVENTION:
Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)

SUMMARY:

      The purpose of the study is to measure tumor response rates for three schedules of
      Alimta(LY231514) in combination with gemcitabine in patients with locally advanced or
      metastatic non small cell lung cancer who have received no prior chemotherapy regimen.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Diagnosis of non-small lung cancer

          -  No prior chemotherapy

          -  Able to care for self

        Exclusion Criteria:

          -  An ongoing infection

          -  Pregnancy or breast feeding

          -  Other serious medical condition

          -  Cancer that has spread to the brain

          -  Inability to take folic acid
      
